Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
535
datasets available to search
ShareScore release 0.9.0
Dataset results
535 results for “Neovascularization”
A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT04450329. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
ClinicalTrials.gov study NCT02581891. IPD Sharing: Not stated. Countries: 8. Publications: 5.
Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab
ClinicalTrials.gov study NCT01810042. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
ClinicalTrials.gov study NCT03823300. IPD Sharing: YES. Countries: 21. Publications: 4.
Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
ClinicalTrials.gov study NCT00284089. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
ClinicalTrials.gov study NCT00436553. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00433017. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Dr
ClinicalTrials.gov study NCT03639675. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
ClinicalTrials.gov study NCT02305238. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration
ClinicalTrials.gov study NCT01089517. IPD Sharing: Not stated. Countries: 1. Publications: 1.
20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01175395. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Topical Avastin for Treatment of Corneal Neovascularization
ClinicalTrials.gov study NCT00559936. IPD Sharing: Not stated. Countries: 1. Publications: 2.
IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD
ClinicalTrials.gov study NCT02462889. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]
ClinicalTrials.gov study NCT04270747. IPD Sharing: Not stated. Countries: 18. Publications: 0.
Carbidopa-levodopa in Neovascular AMD
ClinicalTrials.gov study NCT03022318. IPD Sharing: NO. Countries: 1. Publications: 8.
Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial
ClinicalTrials.gov study NCT03066258. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
ClinicalTrials.gov study NCT02540954. IPD Sharing: NO. Countries: 14. Publications: 1.
12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01362348. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)
ClinicalTrials.gov study NCT00891735. IPD Sharing: Not stated. Countries: 1. Publications: 21.
Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
ClinicalTrials.gov study NCT02396316. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.